Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
I412820-10mg | 10mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $399.90 | |
I412820-25mg | 25mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $699.90 | |
I412820-50mg | 50mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $979.90 | |
I412820-100mg | 100mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $1,359.90 |
Specifications & Purity | Moligand™, ≥98% |
---|---|
Biochemical and Physiological Mechanisms | IL-15-IN-1 is a potent and selective inhibitor of Interleukin 15 (IL-15) that inhibits the proliferation of IL-15-dependent cells with IC50 of 0.8 μM. |
Storage Temp | Protected from light,Store at -20°C |
Shipped In | Ice chest + Ice pads |
Grade | Moligand™ |
Product Description | Information IL-15-IN-1 is a potent and selective inhibitor of Interleukin 15 (IL-15) that inhibits the proliferation of IL-15-dependent cells with IC50 of 0.8 μM. |
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
IUPAC Name | ethyl 3-[8-[[4-methyl-5-[(3-methyl-4-oxophthalazin-1-yl)methyl]-1,2,4-triazol-3-yl]sulfanyl]octanoylamino]benzoate |
---|---|
INCHI | InChI=1S/C30H36N6O4S/c1-4-40-29(39)21-13-12-14-22(19-21)31-27(37)17-8-6-5-7-11-18-41-30-33-32-26(35(30)2)20-25-23-15-9-10-16-24(23)28(38)36(3)34-25/h9-10,12-16,19H,4-8,11,17-18,20H2,1-3H3,(H,31,37) |
InChi Key | GWNFQAKCJYEJEW-UHFFFAOYSA-N |
Canonical SMILES | CCOC(=O)C1=CC(=CC=C1)NC(=O)CCCCCCCSC2=NN=C(N2C)CC3=NN(C(=O)C4=CC=CC=C43)C |
Isomeric SMILES | CCOC(=O)C1=CC(=CC=C1)NC(=O)CCCCCCCSC2=NN=C(N2C)CC3=NN(C(=O)C4=CC=CC=C43)C |
PubChem CID | 129320517 |
Molecular Weight | 576.71 |
Enter Lot Number to search for COA:
Find and download the COA for your product by matching the lot number on the packaging.
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
B2402201 | Certificate of Analysis | Jan 02, 2024 | I412820 |
B2402202 | Certificate of Analysis | Jan 02, 2024 | I412820 |
B2402203 | Certificate of Analysis | Jan 02, 2024 | I412820 |
B2402204 | Certificate of Analysis | Jan 02, 2024 | I412820 |
B2402205 | Certificate of Analysis | Jan 02, 2024 | I412820 |
B2402206 | Certificate of Analysis | Jan 02, 2024 | I412820 |
B2402207 | Certificate of Analysis | Jan 02, 2024 | I412820 |
Solubility | DMSO: 122 mg/mL (211.55 mM), Need ultrasonic |
---|---|
Sensitivity | Light sensitive;Heat sensitive |
1. Mortier E, Quéméner A, Vusio P, Lorenzen I, Boublik Y, Grötzinger J, Plet A, Jacques Y. (2006) Soluble interleukin-15 receptor alpha (IL-15R alpha)-sushi as a selective and potent agonist of IL-15 action through IL-15R beta/gamma. Hyperagonist IL-15 x IL-15R alpha fusion proteins.. J Biol Chem, 281 (3): (1612-9). [PMID:16284400] [10.1021/op500134e] |
2. Quéméner A, Maillasson M, Arzel L, Sicard B, Vomiandry R, Mortier E, Dubreuil D, Jacques Y, Lebreton J, Mathé-Allainmat M. (2017) Discovery of a Small-Molecule Inhibitor of Interleukin 15: Pharmacophore-Based Virtual Screening and Hit Optimization.. J Med Chem, 60 (14): (6249-6272). [PMID:28657314] [10.1021/op500134e] |